Centene Corp.
CNC$64.18
$-2.81 (-4.19%)-4.19%
ClosedLoading chart...
IndexN/A
Market Cap31.70B
Enterprise Value21.10B
Income$1.31B
Sales$46.62B
Employees60,400
P/E25.47
P/S0.10
P/B1.01
P/C4.68
EV/EBITDA-4.10
EV/Sales0.36
EPS (ttm)2.52
Earnings2025-10-29
Gross Margin11.16%
Oper. Margin3.29%
Profit Margin2.81%
Volume4.39M
Shs Outstand0.49B
Change-4.19%
Dividend Est.N/A
Dividend Ex-DateN/A
Perf YTD9.50%
Perf Year-26.51%
Perf 3Y-40.38%
Perf 5Y-27.14%
Perf 10Y46.38%
IPO2001-12-13
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $163.07B | $154.00B | $144.55B | $125.98B | $111.11B | $74.64B | $60.12B | $48.38B |
| Cost of Revenue | $146.24B | $136.68B | $127.89B | $111.78B | $95.90B | $65.80B | $51.70B | $42.58B |
| Gross Profit | $16.83B | $17.32B | $16.66B | $14.20B | $15.22B | $8.84B | $8.42B | $5.80B |
| Gross Margin | 10.32% | 11.24% | 11.52% | 11.27% | 13.69% | 11.85% | 14.01% | 11.99% |
| Operating Expenses | $13.65B | $14.38B | $15.34B | $12.41B | $12.13B | $7.06B | $6.96B | $4.60B |
| Operating Income | $3.17B | $2.93B | $1.32B | $1.78B | $3.08B | $1.78B | $1.46B | $1.20B |
| Operating Margin | 1.95% | 1.90% | 0.91% | 1.42% | 2.77% | 2.39% | 2.43% | 2.48% |
| Net Income | $3.31B | $2.70B | $1.20B | $1.35B | $1.81B | $1.32B | $900.00M | $828.00M |
| Net Margin | 2.03% | 1.75% | 0.83% | 1.07% | 1.63% | 1.77% | 1.50% | 1.71% |
| EPS (Basic) | $6.33 | $4.97 | $2.09 | $2.31 | $3.17 | $3.19 | $2.31 | $2.40 |
| EBITDA | $6.20B | $5.62B | $4.06B | $3.81B | $4.76B | $2.84B | $2.21B | $1.75B |
| Stock Option Compensation Expense | $212.00M | $216.00M | $234.00M | $203.00M | $281.00M | $177.00M | $145.00M | $135.00M |
| Price To Earnings Ratio | 9.56 | 14.92 | 39.24 | 35.65 | 18.95 | 19.68 | 25.00 | 21.02 |
| Price To Sales Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Capitalization | $31.61B | $40.32B | $47.17B | $48.03B | $34.26B | $26.00B | $22.50B | $17.40B |
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Short Term Receivables | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventories | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Property, Plant & Equipment | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Investments and Advances | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Note Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Intangible Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Assets | $82.44B | $84.64B | $76.87B | $78.38B | $68.72B | $40.99B | $30.90B | $21.86B |
| Short Term Debt Incl. Current Port. of LT Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Provision for Risks Charges | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $55.94B | $58.69B | $52.63B | $51.35B | $42.76B | $28.30B | $19.88B | $14.98B |
| Non-Equity Reserves | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Preferred Stock - Carrying Value | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Common Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Shareholders Equity | $26.41B | $25.84B | $24.06B | $26.80B | $25.77B | $12.55B | $10.92B | $6.85B |
| Accumulated Minority Interest | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $26.41B | $25.84B | $24.06B | $26.80B | $25.77B | $12.55B | $10.92B | $6.85B |
| Total Liabilities & Stockholders Equity | $82.44B | $84.64B | $76.87B | $78.38B | $68.72B | $40.99B | $30.90B | $21.86B |
| Book Value Per Share | $50.81 | $47.77 | $42.14 | $46.36 | $45.49 | $30.70 | $28.25 | $19.93 |
| Tangible Book Value Per Share | $6.79 | $4.23 | $-2.58 | $-0.98 | $-1.89 | $9.11 | $4.53 | $2.11 |
| Full-Time Employees | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Book Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | 4.01% | 3.19% | 1.56% | 1.72% | 2.63% | 3.22% | 2.91% | 3.79% |
| Return on Equity | 12.51% | 10.46% | 5.00% | 5.03% | 7.02% | 10.53% | 8.24% | 12.09% |
| Return on Invested Capital | 5.07% | 4.56% | 1.66% | 2.48% | 4.20% | 4.62% | 5.02% | 6.82% |
| Quick Ratio | 1.11 | 1.11 | 1.06 | 1.11 | 1.08 | 1.57 | 1.00 | 0.93 |
| Current Ratio | 1.11 | 1.11 | 1.06 | 1.11 | 1.08 | 1.57 | 1.00 | 0.93 |
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $3.31B | $2.70B | $1.20B | $1.35B | $1.81B | $1.32B | $900.00M | $828.00M |
| Depreciation | $1.24B | $1.29B | $1.43B | $1.33B | $1.26B | $643.00M | $495.00M | $361.00M |
| Other Funds (Non Cash) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Funds from Operations | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Extraordinary Item | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Changes in Working Capital | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Taxes Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Operating Activities | $154.00M | $8.05B | $6.26B | $4.21B | $5.50B | $1.48B | $1.23B | $1.49B |
| Capital Expenditures | $644.00M | $799.00M | $1.00B | $910.00M | $869.00M | $730.00M | $675.00M | $422.00M |
| Net Assets From Acquisitions | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale of Fixed Assets and Businesses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase or Sale of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale Or Maturity of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Sources | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Investing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Dividends Paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Change in Capital Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Repurchase of Common Pref Stock | $3.12B | $1.63B | $3.10B | $297.00M | $626.00M | $75.00M | $71.00M | $65.00M |
| Sale of Common Pref Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Proceeds from Stock Options | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance or Reduction of Debt, Net | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Change in Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Reduction of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Financing Active Other Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Financing Activities Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Financing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Change in Cash | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | $-490.00M | $7.25B | $5.26B | $3.29B | $4.63B | $753.00M | $559.00M | $1.07B |
| Preferred Dividends (Cash Flow) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Company coverage
Latest news
Diamond Hill Small-Mid Cap Fund Q2 2026 Portfolio Reviewseekingalpha.com Superior HealthPlan and Centene Foundation Make $350,000 Investment to Help with Flood Relief in Texasprnewswire.com 4 GARP Stocks With Discounted PEG Ratios and Strong Growth to Buy Nowzacks.com Here's Why Centene (CNC) is a Strong Value Stockzacks.com UnitedHealth vs. Centene: Which Managed Care Stock Is the Better Buy?zacks.com Best Momentum Stock to Buy for July 30thzacks.com Should Value Investors Buy Centene (CNC) Stock?zacks.com Centene Stock Q2 Earnings Call Highlights Margin Recoveryzacks.com
Show 12 more stories
Centene Corporation (CNC) Q2 2026 Earnings Call Transcriptseekingalpha.com Centene Finds Profit Growth Even as Medicaid Membership Softensbenzinga.com Centene Q2 Earnings Beat Estimates on Increasing Premiumszacks.com Centene (CNC) Reports Q2 Earnings: What Key Metrics Have to Sayzacks.com Centene (CNC) Q2 Earnings and Revenues Surpass Estimateszacks.com Centene Reports $1 Billion Profit As Health Insurer's Costs Easeforbes.com Centene Raises 2026 Outlook on Profit, Revenue Growthwsj.com Centene raises annual profit forecast on better cost controlreuters.com CENTENE CORPORATION REPORTS SECOND QUARTER 2026 RESULTSprnewswire.com CENTENE ANNOUNCES BOARD OF DIRECTORS CHANGESprnewswire.com Centene (CNC) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimateszacks.com Is Centene Stock a Smart Buy Ahead of Q2 Earnings? Key Estimateszacks.com
Insider Trading
View AllInsider
Type
Shares
Price
Value
Date
Company
About the company
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
Discover more
You may be interested in